![handle is hein.cbhear/fdsysapjz0001 and id is 1 raw text is: AUT-ENTICATED
US. GOVERNMENT
INFORMATION
GP
DEPARTMENT OF DEFENSE APPROPRIATIONS
FOR FISCAL YEAR 2017
U.S. SENATE,
SUBCOMMITTEE OF THE COMMITTEE ON APPROPRIATIONS,
Washington, DC.
NONDEPARTMENTAL WITNESSES
[CLERK'S NOTE.-The subcommittee was unable to hold hearings
on nondepartmental witnesses. The statements and letters of those
submitting written testimony are as follows:]
PREPARED STATEMENT OF CROHN'S AND COLITIS FOUNDATION OF AMERICA
Chairman Thad Cochran, Ranking Member Durbin, and distinguished members
of the Subcommittee, as you begin to craft the fiscal year 2017 Defense appropria-
tions bill, the Crohn's and Colitis Foundation is pleased to submit this statement
for the record asking you to provide $250 billion for the Department of Defense
(DOD) Peer Reviewed Medical Research Program in addition to listing inflammatory
bowel diseases (IBD) as a condition for study within the program as it has histori-
cally been included since 2008. These actions will ensure further advancements in
understanding the linkage between active service and IBD and how to prevent or
effectively treat these debilitating diseases.
CROHN'S AND COLITIS FOUNDATION OF AMERICA
The Crohn's & Colitis Foundation is the only national nonprofit, voluntary health
organization dedicated to the fight against IBD. Its mission is to cure and prevent
Crohn's disease and ulcerative colitis, and to improve the quality of life of children
and adults affected by these diseases.
The Foundation's Research Program has four major goals:
1) Identity and fund the best peer-reviewed, investigator-initiated research in
IBD;
2) Provide money that allows investigators to generate enough preliminary data
to compete for funding from the National Institutes of Health (NIH);
3) Encourage outstanding investigators to choose a career in IBD research; and
4) Discover and support emerging areas of research that enhance our under-
standing of the causes and disease course of IBD.
Each year, the Foundation's National Scientific Advisory Committee (NSAC)
which is comprised of thought leaders in IBD, conducts a peer review-modeled
after that of the NIH-of more than 250 grant applications annually from all over
the world. Grants are awarded strictly on the basis of scientific merit and relevance
to Crohn's disease and ulcerative colitis. Through this process, the Crohn's & Colitis
Foundation is able to fund only the very best IBD research in the world. The Foun-
dation has played a role in many breakthroughs that have improved the lives of IBD
patients. Of particular mention is the initial research study that led to the discovery
of Remicade@, the only biologic drug available for both Crohn's disease and ulcera-
tive colitis. The Foundation was also integral in funding work that led to identifying
the first gene linked to Crohn's Disease, NOD/CARD15.
DEPARTMENT OF DEFENSE RESEARCH ACTIVITIES
CCFA requests that IBD be listed as a condition eligible for study in the Peer-
Reviewed Medical Research Program in the fiscal year 2017 DOD Appropriations
Bill.
(1)](ViewImageLocal?handle=hein.cbhear/fdsysapjz0001&div=1&collection=&method=preview&ext=.png&size=3)
What Is HeinOnline?
Contact us for annual subscription options:
Already a HeinOnline Subscriber?
profiles profiles most
Contact us for annual subscription options:
Already a HeinOnline Subscriber?
profiles profiles most
Contact us for annual subscription options:
Already a HeinOnline Subscriber?
profiles profiles most